Levosimendan in Aortic Valve Surgery: Cardiac Performance and Recovery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 22, Issue 5, 2008, Pages 693-698

  Järvelä, Kati ^a,b   Maaranen, Pasi ^a   Sisto, Tero ^a   Ruokonen, Esko ^c  

^a PIRKANMAA HOSPITAL DISTRICT   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

aortic stenosis; aortic valve surgery; calcium sensitizers; levosimendan

Indexed keywords

LEVOSIMENDAN; NITROPRUSSIDE SODIUM; NORADRENALIN; PLACEBO;

ADULT; AGED; ANESTHESIA INDUCTION; AORTA STENOSIS; AORTIC VALVE REPAIR; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PERFORMANCE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STUNNED HEART MUSCLE;

AGED; AORTIC VALVE; CALCIUM; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; OXYGEN; PROSPECTIVE STUDIES; PYRIDAZINES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 52149100125     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2008.01.024     Document Type: Article

References (30)

1. Iivanainen A.M., Lindroos M., Tilvis R., et al. Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol 78 (1996) 97-101
2. Mehta R.H., Bruckman D., Das S., et al. Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg 122 (2001) 919-928
3. Chang P.P., Sussman M.S., Conte J.V., et al. Postoperative ventricular function and cardiac enzymes after on-pump versus off-pump CABG surgery. Am J Cardiol 89 (2002) 1107-1110
4. Pölönen P., Ruokonen E., Hippeläinen M., et al. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg 90 (2000) 1052-1059
5. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001) 1368-1377
6. Khot U.N., Novaro G.M., Popovic Z.B., et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 348 (2003) 1756-1763
7. Hasenfuss G., Holubarch C., Heiss H.W., et al. Myocardial energetics in patients with dilated cardiomyopathy: Influence of nitroprusside and enoximone. Circulation 80 (1989) 51-64
8. Scoote M., and Williams A.J. Myocardial calcium signalling and arrhythmia pathogenesis. Biochem Biophys Res Commun 322 (2004) 1286-1309
9. Stuver T.P., Cove C.J., and Hood Jr. W.B. Mechanical abnormalities in the rat ischemic heart failure model which lie downstream to cAMP production. Mol Cell Cardiol 26 (1994) 1221-1226
10. Gao D.W., Atar D., Backx P.H., et al. Relationship between intracellular calcium and contractile force in stunned myocardium. Circ Res 76 (1995) 1036-1048
11. Haikala H., Nissinen E., Etemadzadeh E., et al. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 25 (1995) 794-801
12. Haikala H., and Linden I.B. Mechanisms of action of calcium-sensitizing drugs. J Cardiovasc Pharmacol 6 suppl 1 (1995) S10-S19
13. Kloner R.A., Przyklenk K., and Kay G.L. Clinical evidence for stunned myocardium after coronary artery bypass surgery. J Card Surg 9 suppl 3 (1994) S397-S402
14. Varpula M., Karlsson S., Ruokonen E., et al. Mixed venous saturation cannot be estimated by central venous oxygen saturation in septic shock. Intensive Care Med 32 (2006) 1336-1343
15. Faggiano P., Rusconi C., Sabatini T., et al. Congestive heart failure in patients with valvular aortic stenosis. Cardiology 86 (1995) 120-129
16. Bernard F., Denault A., Babin D., et al. Diastolic dysfunction is predictive of difficult weaning from cardiopulmonary bypass. Anesth Analg 92 (2001) 291-298
17. De Luca L., Sardella G., Proietti P., et al. Effects of levosimendan on left ventricular diastolic function after primary angioplasty for acute anterior myocardial infarction: A Doppler echocardiographic study. J Am Soc Echocardiogr 19 (2006) 172-177
18. O′Connor C.M., Gattis W.A., Uretsky B.F., et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 138 (1999) 78-86
19. Yokoshiki H., Katsube Y., Sunagawa M., et al. Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes. Eur J Pharmacol 333 (1997) 249-259
20. Cole W.C., McPherson C.D., and Sontag D. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res 69 (1991) 571-581
21. Tritapepe L., De Santis V., Vitale D., et al. Preconditioning effects of levosimendan in coronary artery bypass grafting-A pilot study. Br J Anaesth 96 (2006) 694-700
22. Morelli A., De Castro S., Teboul J.-L., et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31 (2005) 638-644
23. Nijhawan N., Nicolosi A., Montgomery M.W., et al. Levosimendan enhances cardiac performance after cardiopulmonary bypass: A prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol 34 (1999) 219-228
24. Barisin S., Husedzinovic I., Sonicki Z., et al. Levosimendan in off-pump coronary artery bypass. J Cardiovasc Pharmacol 44 (2004) 703-708
25. Lilleberg J., Nieminen M.S., Akkila J., et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 19 (1998) 660-668
26. De Hert S.G., Lorsomradee S., Cromheecke S., et al. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 1004 (2007) 766-773
27. De Ruijter W., Musters R.J.P., Boer C., et al. The cardioprotective effect of sevoflurane depends on protein kinase C activation, opening of mitochondrial K+ ATP channels, and the production of reactive oxygen species. Anesth Analg 97 (2003) 1370-1376
28. Varadajan S.G., An J., Novalija E., et al. Sevoflurane before or after ischemia improves contractile and metabolic function while reducing myoplasmic Ca2+ loading in intact hearts. Anesthesiology 96 (2002) 125-133
29. Levosimendan in patients with cardiac dysfunction before major non-cardiac surgery. Wiener Klinisches Magazin (2007) II-IV April
30. Mebazaa A., Nieminen M.S., Packer M., et al., SURVIVE Investigators. Levosimendan vs dobutamine for patients with acute decompensated heart failure. JAMA 297 (2007) 1883-1891